Related Party Transactions (Details Narrative) - USD ($)			1 Months Ended		12 Months Ended
	Oct. 02, 2018	Dec. 31, 2017	May 31, 2018	Apr. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Due to related party		$ 730,629			$ 4,392	$ 730,629
Number of stock issued during the period, shares			51,988
Proceeds from notes payable due to related party						500,000
Loss on settlement of debt					(810,219)
Aggregate of cancellation shares, value					46,311
BioMauris, LLC [Member]
Due to related party					23,585
Paid to related party for services					572,381
BioMauris, LLC [Member] | Acutus Medical [Member]
Paid to related party for services					62,576
Philip C. Ranker [Member]
Options to purchase share			200,000
Exercise price of common shares			$ 0.98
Philippe P. Calais [Member]
Options to purchase share			80,000
Exercise price of common shares			$ 0.98
Joseph W. Ramelli [Member]
Severance payments			$ 60,000
Exercisable period			5 years
Exercise price of common stock			$ 0.98
Dr. Trieu [Member]
Salary received amount per month					20,000
Robert Moscato [Member] | Interior Design Services [Member]
Paid to related party for services					$ 15,983
Warrants [Member]
Warrant term					5 years
Exercise price of warrants					$ 0.55
Fair value of warrant					$ 1,494,469
Loss on settlement of debt					$ 754,697
Maximum [Member] | Joseph W. Ramelli [Member]
Number of exercisable options grants			100,000
Series E Preferred Stock [Member]
Aggregate of cancellation shares					9
Aggregate of cancellation shares, value
Autotelic [Member]
Billed expenses					795,228	791,889
Personnel cost					531,794	$ 558,098
Master Services Agreement [Member]
Proceeds from common or preferred stock, gross					$ 10,000,000
Compensation description					After the Equity Financing Date, the Company paid Autotelic Inc. a cash amount equal to the actual labor cost plus 100% mark up of provided services and 20% mark up of provided services by third party contractors or material used in connection with the performance of the contracts, including but not limited to clinical trial, non-clinical trial, Contract Manufacturing Organizations ("CMO"), FDA regulatory process, Contract Research Organizations ("CRO") and Chemistry and Manufacturing Controls ("CMC").
Master Services Agreement [Member] | Related Party [Member]
Service provider percentage					20.00%
Settlement Agreement with Autotelic Inc [Member] | Maximum [Member]
Warrants to purchase common shares				1,345,040
Settlement Agreement with Autotelic Inc [Member] | Series E Preferred Stock [Member]
Number of stock issued during the period, shares				162.59
Proceeds from notes payable due to related party				$ 812,967
Accrued and unpaid fees				$ 739,772
Compromise and Settlement Agreements [Member] | Board of Directors [Member]
Number of stock issued during the period, shares				58.25
Accrued and unpaid fees		$ 291,250
Compromise and Settlement Agreements [Member] | Two Farmer Directors [Member]
Payments Related to Tax Withholding				$ 95,000
Compromise and Settlement Agreements [Member] | Maximum [Member] | Board of Directors [Member]
Warrants to purchase common shares				436,875
Omnibus Settlement Agreement [Member] | Dr. Trieu [Member]
Due to related party	$ 10,000
Aggregate of cancellation shares	500,000
Aggregate of cancellation shares, value	$ 250,000
Autotelic Inc. [Member] | Master Services Agreement [Member]
Ownership interest					5.00%